← Leaderboards
Santhoshkumar Puttur
University Of Missouri-Columbia
$426,250
Attributed
$426,250
Total exposure
1
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $232.5K · FY2018–19$250K$187.5K$125K$62.5K$0
'18
'19
Funding mix
By agency
NIH$426,250 · 1
By mechanism
R21$426,250 · 1
Top collaborators
No co-investigators on record.
Most similar at University Of Missouri-Columbia
Same institution · by research overlap
- Krishna K Sharma$12,671,601
- Beryl J Ortwerth$2,645,070
- Xiaoqin Zou$6,077,987
- Meredith Hay$10,722,587
- Marjorie Skubic$2,625,571
Others in their field
Other Emerging Leaders on “Active Sites”
- Sonia M Thomas · Research Triangle Institute$701,865,642
- Bambra Strokes · Ppd Development Lp$526,656,217
- Tracy L Nolen · Research Triangle Institute$474,487,152
- Peter K Fritschel · California Institute Of Technology$78,820,000
- Martha Hering · Westat, Inc.$57,098,843
- Susan Abushakra · Alzheon, Inc.$50,765,244
Research focus
Active SitesAffectAlzheimer&AposAmino AcidsAmyloid DepositionAnimal ModelApoptosisApoptoticAssociated SymptomBindingBiological PreservationBiological ProcessBody PartCataractCell DeathCellsCell TypeCessation Of LifeCorneaCorneal Granular DystrophiesCost Of IllnessCreutzfeldt-Jakob SyndromeCrystallinsAbeta Oligomer
Grant awards (2)
Cell-Penetrable and in vivo activatable mini-chaperones: A potential therapeutic strategy for stabilizing protein misfolding in disease states.$193,750
R21 · FY2019 · EY · contact PI
Cell-Penetrable and in vivo activatable mini-chaperones: A potential therapeutic strategy for stabilizing protein misfolding in disease states.$232,500
R21 · FY2018 · EY · contact PI